Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · November 11, 2024

Associations of Semaglutide With First-Time Diagnosis of Alzheimer's Disease in Patients With Type 2 Diabetes

Alzheimer's & Dementia

 

Additional Info

Disclosure statements are available on the authors' profiles:

Alzheimer's & Dementia
Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US
Alzheimers Dement 2024 Oct 24;[EPub Ahead of Print], W Wang, Q Wang, X Qi, M Gurney, G Perry, ND Volkow, PB Davis, DC Kaelber, R Xu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading